Cargando…

Non-contrast T1rho CMR for hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Wang, Chunhua, Zheng, Jie, Sun, Jiayu, Wang, Yuqing, Xia, Rui, Yin, Qian, Chen, Wei, Liao, Jichun, Zhang, Bing, Gao, Fabao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328851/ http://dx.doi.org/10.1186/1532-429X-17-S1-P273

Ejemplares similares

CMR assessment of hypertrophic cardiomyopathy with restrictive phenotype
por: Lu, Minjie, et al.
Publicado: (2015)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

Stress perfusion CMR in hypertrophic cardiomyopathy: comparison with late gadolinium enhancement
por: Villa, Adriana, et al.
Publicado: (2014)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
por: Flett, Andrew S, et al.
Publicado: (2009)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
por: Gommans, Frank, et al.
Publicado: (2012)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
por: Abdel-Aty, Hassan, et al.
Publicado: (2012)

CMR detects abnormal septal convexity into the left ventricle in preclinical hypertrophic cardiomyopathy
por: Reant, Patricia, et al.
Publicado: (2015)

Maximal left ventricular wall thickness: a comparison between CMR and echocardiography in hypertrophic cardiomyopathy
por: Corona-Villalobos, Celia P, et al.
Publicado: (2013)

The evolution and clinical importance of scar in hypertrophic cardiomyopathy - a 7 year CMR follow-up study
por: Quarta, Giovanni, et al.
Publicado: (2011)

Relationship between myocardial scar and hypertrophy by LGE CMR in hypertrophic cardiomyopathy patients with and without clinical events
por: Kino, Aya, et al.
Publicado: (2012)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

Cardiac magnetic resonance imaging (CMR) characteristics in apical versus non-apical hypertrophic cardiomyopathy (HCM)
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2016)

Hypertrophic cardiomyopathy and fibrosis: correlation between late gadolinium enhancement on CMR and speckle tracking imaging using Ultrasound
por: Cautela, Jennifer, et al.
Publicado: (2015)

The early role of CMR in the assessment of cardiomyopathy
por: Barrett, Matthew, et al.
Publicado: (2012)

Lower-than-normal myocardial stress and excess hypertrophy from CMR are associated with worsening ventricular contractile performance in hypertrophic cardiomyopathy
por: Zhong, Liang, et al.
Publicado: (2016)

T1 mapping by CMR in patients with arrhythmic cardiomyopathy
por: Zhao, Lei, et al.
Publicado: (2015)

Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric CMR predictors beyond end-diastolic wall thickness ≥15mm
por: Rodrigues, Jonathan C, et al.
Publicado: (2016)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Ischemic postconditioning diminishes intramyocardial hemorrhage in acute reperfused myocardial infarction in rats, evaluated by CMR at 7T
por: Zhang, Bing, et al.
Publicado: (2015)

Diagnostic accuracy of different CMR techniques in the evaluation of ischemic cardiomyopathy
por: Won, Eugene, et al.
Publicado: (2013)

Evaluation of CMR predictors of right ventricular remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Evaluation of left ventricular outflow tract obstruction with 4D phase contrast in patients with hypertrophic cardiomyopathy
por: Chu, Linda, et al.
Publicado: (2014)

Assessment of the interstitial volume in healthy volunteers. An equilibrium contrast CMR study
por: Sado, Daniel, et al.
Publicado: (2012)

Delineation of anthracyclines and herceptin induced cardiotoxicity using contrast enhanced CMR
por: Hamirani, Yasmin S, et al.
Publicado: (2014)

Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration
por: Captur, Gaby, et al.
Publicado: (2014)

Assessment of myocardial and LV blood pool post-contrast T1 evolution: comparison between healthy subjects and patients with hypertrophic cardiomyopathy
por: Kachenoura, Nadjia, et al.
Publicado: (2013)

CMR of LV non-compaction cardiomyopathy: association of clinical presentation and prognosis with cardiac phenotype
por: Syed, Mushabbar A, et al.
Publicado: (2011)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2013)

The impact of new proposed arrhythmogenic right ventricular cardiomyopathy (ARVC) criteria on CMR diagnosis
por: Natale, Luigi, et al.
Publicado: (2013)

Replacement fibrosis detected by CMR is a predictor of outcome in patients with non-ischemic cardiomyopathy
por: Ghosn, Mohamad G, et al.
Publicado: (2014)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
por: Roussin, Isabelle, et al.
Publicado: (2009)

Gene database for the development of genetic testing for hypertrophic cardiomyopathy
por: Silas, Justin Carlus, et al.
Publicado: (2014)

Left atrial remodeling and mechanical dysfunction in hypertrophic cardiomyopathy
por: Kim, Kyung-Jin, et al.
Publicado: (2016)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Biatrial performance in children with hypertrophic cardiomyopathy: CMR study
por: Mazurkiewicz, Łukasz, et al.
Publicado: (2018)

High signal intensity on T2 weighted cardiac magnetic resonance imaging in hypertrophic cardiomyopathy: Is it a marker of myocardial injury?
por: Chen, Shi, et al.
Publicado: (2015)

Mitral valve leaflet length as an important factor to differentiate hypertrophic cardiomyopathy from other causes of left ventricular hypertrophy
por: Luo, Yong, et al.
Publicado: (2016)

Visualisation of aortic flow disturbance in Marfan syndrome by 4D phase-contrast CMR
por: Pitcher, Alex, et al.
Publicado: (2011)

The clinical value of phase-contrast CMR mitral inflow diastolic parameters: comparison with echocardiography
por: Bollache, Emilie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l3bnttqbae8q9cpoaq4vihumuh